Managers / Q2 2020 · view latest →
TimeScale Financial, Inc.
CIK 0001765054 · 222 ROSEWOOD DRIVE 2ND FLOOR, DANVERS, MA, 01923 · 9787773116
Summary
Timescale Financial, Inc. reported $323M in U.S.-listed holdings across 475 positions for Q2 2020.
The portfolio is heavily concentrated: IVV alone accounts for 26.0% of reported value.
Compared with Q1 2020, the fund opened 63 new positions and exited 23.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 92.2% · $298M
- Common Stock · 7.3% · $24M
- Other · 0.2% · $681,000
- REIT · 0.2% · $677,000
- ADR · 0.0% · $156,000
- Other · 0.0% · $130,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPDWSPDR PORTFOLIO DEVELOPED WORLD EX-US ETF | NEW | +8.7K | 8.7K | +$242,000 | $242,000 |
| BONDPIMCO ACTIVE BOND EXCHANGE-TRADED FUND | NEW | +1.4K | 1.4K | +$158,000 | $158,000 |
| SPDR PORTFOLIO EMERGING MARKETS ETF | NEW | +1.9K | 1.9K | +$65,000 | $65,000 |
| ISRGINTUITIVE SURGICAL INC COM NEW | NEW | +59 | 59 | +$34,000 | $34,000 |
| ALXNALEXION PHARMACEUTICALS INC COM | NEW | +214 | 214 | +$24,000 | $24,000 |
| PHYSICIANS RLTY TR COM | NEW | +1.1K | 1.1K | +$19,000 | $19,000 |
| IEFAISHARES CORE MSCI EAFE ETF | NEW | +210 | 210 | +$12,000 | $12,000 |
| SEATTLE GENETICS INC COM | NEW | +66 | 66 | +$11,000 | $11,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2023 | $463M | 628 | Jul 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $441M | 624 | Apr 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $344M | 593 | Feb 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $344M | 593 | Oct 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $365M | 563 | Jul 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $425M | 562 | Apr 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $447M | 561 | Jan 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $415M | 538 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $420M | 539 | Jul 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $387M | 537 | Apr 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $365M | 457 | Jan 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $342M | 486 | Oct 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $323M | 475 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $321M | 509 | Apr 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $334M | 553 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $296M | 520 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $271M | 545 | Jul 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $227M | 86 | Apr 3, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $173M | 91 | Feb 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.